Tag: Neurovascular

MicroVention® Announces FDA Approval For Neuro Stent Device

ALISO VIEJO, Calif., May 31, 2018 /PRNewswire/ — MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS® and LVIS® Jr. stents for stent-assisted coil embolization of intracranial aneurysms. The LVIS® and LVIS® Jr. stents are the first and only stents PMA approved for […]

MIVI Neuroscience Begins European Commercialization After Achieving CE Mark Approval Of The R4Q Revascularization Catheter For Ischemic Stroke

EDEN PRAIRIE, Minn., March 29, 2018 /PRNewswire/ — MIVI Neuroscience, Inc. announced today it has received CE Mark approval for the R4Q Revascularization Catheter for the removal of fresh, soft emboli and thrombi in the peripheral and neurovascular systems. The CE Mark approval is a significant accomplishment for MIVI Neuroscience.  This approval enables the […]

The global neurovascular devices market is expected to grow at a CAGR of 10.3%

LONDON, March 14, 2018 /PRNewswire/ — Download the full report: https://www.reportbuyer.com/product/5351730 Report Details The global neurovascular devices market is expected to grow at a CAGR of 10.3% in the first half of the forecast period. In 2016, the Cerebral Embolization and Aneurysm Coiling Devices segment held the largest share in the global neurovascular […]

Neurovascular Embolization Coils: Healthcare Provider Letter – Potential for Increased Image Artifact When Using Magnetic Resonance Angiography For Follow-Up

ISSUE: The FDA is providing information about the potential for increased image artifact associated with Magnetic Resonance Angiography (MRA) imaging for patient follow-up of certain post neurovascular embolization coil procedures. Neurovascular embolization coils are used in the treatment of brain aneurysms and other vascular abnormalities. These coils are prescription devices […]

Perflow Medical Closes $12 Million in Financing to Treat Complex Neurovascular Disorders

TEL AVIV, Israel, Feb. 15, 2018 /PRNewswire/ — Perflow Medical, an Israeli-based medical device company that develops innovative tools for neurovascular interventions, today announced that the company has closed $12 million in financing. The syndicate included existing investors, two new international investors, and an unnamed strategic investor. Following a recent launch in Europe, Perflow stated that […]

INDEPENDENT STUDY REAFFIRMS PENUMBRA ASPIRATION AS FRONTLINE THROMBECTOMY APPROACH FOR ACUTE ISCHEMIC STROKE

Results of COMPASS Trial Presented at International Stroke Conference LOS ANGELES – Jan. 25, 2018 – Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced the presentation of the results of the COMPASS Trial, an independent, prospective, multi-center randomized trial that showed the use of […]

NEW STUDY SHOWS USE OF EMBOTRAP® DEVICE CLOT RETRIEVER DURING TREATMENT OF STROKE YIELDS POSITIVE RATES OF REVASCULARIZATION

ARISE II Clinical Trial Results Presented at International Stroke Conference LOS ANGELES – Jan. 25, 2018 – EMBOTRAP® Device, a device designed to remove clots from the brain following an ischemic stroke, demonstrated high success rates in restoring blood flow and patients achieved high rates of functional independence, according to […]

ASPIRATION FIRST APPROACH WITH PENUMBRA SYSTEM DEMONSTRATES FAVORABLE OUTCOMES FOR ACUTE ISCHEMIC STROKE

Results of the PROMISE Study Presented at International Stroke Conference LOS ANGELES – January 25, 2018 – Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced results of the company-sponsored PROMISE Study, demonstrating real-world safety and efficacy of the Penumbra System with ACE™68 and ACE™64 […]

Robocath raises a total of €6.4 million ($7.6M) in 2017

Robocath receives an additional €1.25 million financial contribution from Crédit Agricole Innovations et Territoires (CAIT), an innovation fund managed by Supernova Invest. In line with the company’s growth strategy, the new funding aims to increase the resources available to market the R-OneTM product and launch the development of the next generation of […]

InspireMD Announces Expansion of its Distribution Network for CGuard™ EPS in Australia, New Zealand and Vietnam

TEL AVIV, lSRAEL, Dec. 04, 2017 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed Diverse Devices Pty Ltd as its exclusive distributor for Australia and New Zealand, and has signed Do Gia Production […]